Movement Disorders (revue) - Exploration (Accueil)

Index « Mesh.i » - entrée « Biological Markers »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Biological Clocks < Biological Markers < Biological Specimen Banks  Facettes :

List of bibliographic references indexed by Biological Markers

Number of relevant bibliographic references: 50.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000296 (2015) Martijn L T M. Müller [États-Unis] ; Nicolaas I. Bohnen ; Vikas Kotagal ; Peter J H. Scott ; Robert A. Koeppe ; Kirk A. Frey ; Roger L. AlbinClinical markers for identifying cholinergic deficits in Parkinson's disease.
000359 (2014) Brit Mollenhauer [Allemagne] ; Lynn Rochester [Royaume-Uni] ; Alice Chen-Plotkin [États-Unis] ; David Brooks [Royaume-Uni, Danemark]What Can Biomarkers Tell Us About Cognition in Parkinson's Disease?
000424 (2014) Sylvia Boesch [Autriche] ; Wolfgang Nachbauer ; Caterina Mariotti ; Francesco Sacca ; Alessandro Filla ; Thomas Klockgether ; Thomas Klopstock ; Ludger Schöls ; Heike Jacobi ; Boriana Büchner ; Jennifer Müller Vom Hagen ; Lorenzo Nanetti ; Karen ManicomSafety and tolerability of carbamylated erythropoietin in Friedreich's ataxia.
000475 (2014) Natália Pessoa Rocha [Brésil] ; Antônio Lúcio Teixeira ; Paula Luciana Scalzo ; Izabela Guimarães Barbosa ; Mariana Soares De Sousa ; Isabela Boechat Morato ; Erica Leandro Marciano Vieira ; Paulo Pereira Christo ; András Palotás ; Helton José ReisPlasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease.
000527 (2014) Elizabeth H. AylwardMRI Striatal Volumes – A Biomarker for Clinical Trials in HD
000540 (2014) David Burn [Royaume-Uni] ; Daniel Weintraub [États-Unis] ; Trevor Robbins [Royaume-Uni]Introduction: The Importance of Cognition in Movement Disorders
000585 (2014) Carlos Hernández-Lahoz [Espagne] ; Luis Rodrigo-Sáez ; Juan Vega-Villar ; Gerard Mauri-Capdevila ; Jorge Mier-JuanesFamilial gluten ataxia.
000636 (2014) James R. Burrell [Australie] ; John R. Hodges ; James B. RoweCognition in corticobasal syndrome and progressive supranuclear palsy: a review.
000637 (2014) David Burn [Royaume-Uni] ; Daniel Weintraub [États-Unis] ; Bernard Ravina [États-Unis] ; Irene Litvan [États-Unis]Cognition in Movement Disorders: Where Can We Hope to be in Ten Years?
000670 (2014) Naomi P. Visanji [Canada] ; Connie Marras ; Lili-Naz Hazrati ; Louis W C. Liu ; Anthony E. LangAlimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
000687 (2014) Jose A. Santiago [États-Unis] ; Judith A. PotashkinA network approach to diagnostic biomarkers in progressive supranuclear palsy.
000772 (2013) Jose A. Santiago [États-Unis] ; Clemens R. Scherzer [États-Unis] ; Harvard Biomarker Study [États-Unis] ; Judith A. Potashkin [États-Unis]Specific splice variants are associated with Parkinson’s disease
000874 (2013) Fay B. Horak ; Martina ManciniObjective Biomarkers of Balance and Gait for Parkinson’s Disease using Body-worn Sensors
000923 (2013) Gordon W. Duncan [Royaume-Uni] ; Michael J. Firbank ; John T. O'Brien ; David J. BurnMagnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?
000999 (2013) Daniela Berg [Allemagne] ; Stefanie Behnke ; Klaus Seppi ; Jana Godau ; Stefanie Lerche ; Philipp Mahlknecht ; Inga Liepelt-Scarfone ; Christoph Pausch ; Niko Schneider ; Alexandra Gaenslen ; Kathrin Brockmann ; Karin Srulijes ; Heiko Huber ; Isabel Wurster ; Heike Stockner ; Stefan Kiechl ; Johann Willeit ; Arno Gasperi ; Klaus Fassbender ; Thomas Gasser ; Werner Poewe [Autriche]Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.
000A05 (2013) Jun Hua [États-Unis] ; Paul G. Unschuld [États-Unis, Suisse] ; Russell L. Margolis [États-Unis] ; Peter C. M. Van Zijl [États-Unis] ; Christopher A. Ross [États-Unis]Elevated Arteriolar Cerebral Blood Volume in Prodromal Huntington’s Disease
000A86 (2013) Pankaj A. Agarwal [Canada] ; A Jon StoesslBiomarkers for trials of neuroprotection in Parkinson's disease.
000B44 (2013) Peter A. Lewitt [États-Unis] ; Jia Li ; Mei Lu ; Thomas G. Beach ; Charles H. Adler ; Lining Guo3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis.
000C54 (2012) Johannes R. Streffer [Belgique] ; Igor D. Grachev ; Cheryl Fitzer-Attas ; Baltazar Gomez-Mancilla ; Babak Boroojerdi ; Juliana Bronzova ; Susanne Ostrowitzki ; Stephen J. Victor ; Paulo Fontoura ; Robert AlexanderPrerequisites to launch neuroprotective trials in Parkinson's disease: an industry perspective.
000D39 (2012) Kathleen M. Shannon [États-Unis] ; Ali Keshavarzian ; Hemraj B. Dodiya ; Shriram Jakate ; Jeffrey H. KordowerIs alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
000D52 (2012) Ivan Rektor [République tchèque] ; David Goldemund ; Petr Bedna K ; Kate Ina Sheardová ; Zuzana Michálková ; Sabina Telecká ; Michal Dufek ; Irena RektorováImpairment of brain vessels may contribute to mortality in patients with Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Biological Markers" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Biological Markers" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Biological Markers
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024